Hodges Capital Management »

Halozyme Therapeutics shares owned by Hodges Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Hodges Capital Management from 13F filings

Historical chart of Hodges Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Hodges Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Hodges Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.8M 120k 73.34
2025-06-30 $7.9M 152k 52.02
2025-03-31 $12M 194k 63.81
2024-12-31 $16M 333k 47.81
2024-09-30 $18M 321k 57.24
2024-06-30 $18M 339k 52.36
2024-03-31 $13M 317k 40.68